Repare Therapeutics Inc
NASDAQ:RPTX
Repare Therapeutics Inc
NASDAQ:RPTX
Price:
2.65
USD
Market Cap:
$114.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
CA |
|
Corteva Inc
NYSE:CTVA
|
US |
|
A
|
Asseco Poland SA
WSE:ACP
|
PL |
|
S
|
Sotoh Co Ltd
TSE:3571
|
JP |
|
T
|
Tuya Inc
NYSE:TUYA
|
CN |
|
N
|
Nature Wood Group Ltd
NASDAQ:NWGL
|
MO |
Balance Sheet
Balance Sheet Decomposition
Repare Therapeutics Inc
Repare Therapeutics Inc
Balance Sheet Decomposition is not available for
Repare Therapeutics Inc
Repare Therapeutics Inc
Balance Sheet
Repare Therapeutics Inc
Repare Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
11
|
95
|
326
|
334
|
160
|
111
|
85
|
|
| Cash Equivalents |
11
|
95
|
326
|
334
|
160
|
111
|
85
|
|
| Short-Term Investments |
0
|
0
|
8
|
7
|
184
|
112
|
68
|
|
| Total Receivables |
1
|
3
|
6
|
3
|
4
|
15
|
12
|
|
| Other Current Assets |
0
|
1
|
7
|
6
|
6
|
5
|
6
|
|
| Total Current Assets |
12
|
99
|
347
|
351
|
354
|
244
|
171
|
|
| PP&E Net |
2
|
3
|
9
|
13
|
10
|
8
|
4
|
|
| PP&E Gross |
2
|
3
|
9
|
13
|
10
|
8
|
4
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
5
|
7
|
9
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Other Long-Term Assets |
0
|
1
|
2
|
4
|
1
|
0
|
0
|
|
| Total Assets |
14
N/A
|
103
+639%
|
357
+248%
|
369
+3%
|
364
-1%
|
254
-30%
|
177
-30%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
2
|
2
|
1
|
2
|
4
|
|
| Accrued Liabilities |
0
|
2
|
7
|
20
|
24
|
26
|
21
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
2
|
13
|
55
|
10
|
0
|
|
| Total Current Liabilities |
2
|
4
|
11
|
35
|
79
|
39
|
25
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
9
|
59
|
45
|
6
|
3
|
0
|
|
| Total Liabilities |
4
N/A
|
13
+191%
|
70
+449%
|
80
+14%
|
85
+5%
|
42
-51%
|
25
-39%
|
|
| Equity | ||||||||
| Common Stock |
32
|
136
|
384
|
481
|
482
|
483
|
487
|
|
| Retained Earnings |
23
|
50
|
103
|
210
|
239
|
333
|
418
|
|
| Additional Paid In Capital |
0
|
4
|
6
|
18
|
37
|
62
|
82
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
10
N/A
|
90
+846%
|
287
+219%
|
288
+1%
|
280
-3%
|
212
-24%
|
151
-29%
|
|
| Total Liabilities & Equity |
14
N/A
|
103
+639%
|
357
+248%
|
369
+3%
|
364
-1%
|
254
-30%
|
177
-30%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
35
|
35
|
37
|
42
|
42
|
42
|
43
|
|
Switch to:
Switch to:
See Also
Discover More
